ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases

Autor(es):Mostrar menos -

Neves, Raquel Leao ; Branquinho, Jessica ; Arata, Julia Galanakis ; Bittencourt, Clarissa Azevedo ; Gomes, Caio Perez ; Riguetti, Michelle ; da Mata, Gustavo Ferreira ; Fernandes, Danilo Euclides ; Icimoto, Marcelo Yudi ; Kirsztajn, Gianna Mastroianni ; Pesquero, Joao Bosco

• Tipo de documento: Artigo Científico
• Fonte: Inflammation Research; v. 72, n. 8, p. 13-pg., 2023-08-03.

Resumo

Objective and designCirculating enzymatic activity and RAAS regulation in severe cases of COVID-19 remains unclear, therefore we measured the serum activity of several proteases as potential targets to control the SARS-CoV-2 infection.Material or subjects152 patients with COVID-19-like symptoms were grouped according to the severity of symptoms (COVID-19 negative, mild, moderate and severe).MethodsSerum samples of COVID-19 patients and controls were subjected to biochemical analysis and enzymatic assays of ACE2, ACE, DPPIV, PREP and CAT L. One-way ANOVA and multivariate logistic regression analysis were used. Statistical significance was accepted at p < 0.05.ResultsWe detected a positive correlation among comorbidities, higher C-reactive protein (CRP) and D-dimer levels with disease severity. Enzymatic assays revealed an increase in serum ACE2 and CAT L activities in severe COVID-19 patients, while ACE, DPPIV and PREP activities were significantly reduced. Notably, analysis of ACE2/ACE activity ratio suggests a possible imbalance of ANG II/ANG(1-7) ratio, in a positive association with the disease severity.ConclusionOur findings reveal a correlation between proteases activity and the severity of COVID-19. These enzymes together contribute to the activation of pro-inflammatory pathways, trigger a systemic activation of inflammatory mediators, leading to a RAAS dysregulation and generating a significant damage in several organs, contributing to poor outcomes of severe cases. (AU)

• Processo FAPESP: 19/01487-7 - Nanopartículas de ouro associadas à cisteíno-proteases derivadas de Bromelaína: caracterização estrutural e ação colagenolítica
• Beneficiário: Marcelo Yudi Icimoto
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 14/27198-8 - Estabelecimento de um centro de pesquisa genética e molecular para desafios clínicos
• Beneficiário: João Bosco Pesquero
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 19/05266-5 - Pesquisa e caracterização funcional de mutações em Glomeruloesclerose segmentar e focal familiar e esporádica.
• Beneficiário: Gianna Mastroianni Kirsztajn
• Modalidade de apoio: Auxílio à Pesquisa - Regular